ATE443707T1 - Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität - Google Patents

Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität

Info

Publication number
ATE443707T1
ATE443707T1 AT05816247T AT05816247T ATE443707T1 AT E443707 T1 ATE443707 T1 AT E443707T1 AT 05816247 T AT05816247 T AT 05816247T AT 05816247 T AT05816247 T AT 05816247T AT E443707 T1 ATE443707 T1 AT E443707T1
Authority
AT
Austria
Prior art keywords
indole derivatives
isoxazoline
receptors
anxiolytic activity
towards dopamine
Prior art date
Application number
AT05816247T
Other languages
English (en)
Inventor
Jose I Andres-Gil
Jose M Bartolome-Nebreda
Manuel J Alcazar-Vaca
M Garcia-Martin
Antonius Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE443707T1 publication Critical patent/ATE443707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05816247T 2004-11-26 2005-11-25 Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität ATE443707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106123 2004-11-26
PCT/EP2005/056229 WO2006056600A1 (en) 2004-11-26 2005-11-25 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity

Publications (1)

Publication Number Publication Date
ATE443707T1 true ATE443707T1 (de) 2009-10-15

Family

ID=34929957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05816247T ATE443707T1 (de) 2004-11-26 2005-11-25 Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität

Country Status (10)

Country Link
US (1) US7635696B2 (de)
EP (1) EP1819713B1 (de)
JP (1) JP2008521771A (de)
CN (1) CN101084225B (de)
AT (1) ATE443707T1 (de)
AU (1) AU2005308778B2 (de)
CA (1) CA2585857A1 (de)
DE (1) DE602005016836D1 (de)
ES (1) ES2331144T3 (de)
WO (1) WO2006056600A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010012121A1 (zh) * 2008-07-28 2010-02-04 江苏国华投资有限公司 芳烷基哌啶（嗪）衍生物及其在治疗精神分裂症中的应用
WO2010040274A1 (zh) * 2008-10-10 2010-04-15 中国人民解放军军事医学科学院毒物药物研究所 新型多巴胺d3受体配体，其制备方法及其医药用途
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
EP2263672A1 (de) * 2009-05-19 2010-12-22 Bioprojet Neuartige pharmazeutisch unbedenkliche Salze von 4-(1H-Imidazol-4-ylmethyl)pyridin und ihre therapeutischen Verwendungen
EP2796456A1 (de) * 2010-12-09 2014-10-29 Amgen Inc. Bicyclische Verbindungen als PIM-Hemmer
US9321756B2 (en) 2011-03-22 2016-04-26 Amgen Inc. Azole compounds as PIM inhibitors
WO2023114325A1 (en) * 2021-12-15 2023-06-22 Delix Therapeutics, Inc. Constrained amine psychoplastogens and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965595A (en) 1993-07-01 1999-10-12 The Procter & Gamble Company 2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
US5698571A (en) 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
WO1998022455A1 (fr) 1996-11-19 1998-05-28 Kyowa Hakko Kogyo Co., Ltd. Composes heterocycliques d'oxygene
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
AR015036A1 (es) 1998-04-29 2001-04-11 American Home Prod Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento
TW546299B (en) 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines
US6313126B1 (en) 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
AU2494300A (en) 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
AR028475A1 (es) 1999-04-22 2003-05-14 Wyeth Corp Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
WO2000069424A2 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
FR2797874B1 (fr) 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2002048105A2 (en) 2000-11-16 2002-06-20 Wyeth Aryloxy piperidinyl derivatives for the treatment of depression
EP1349848A2 (de) 2000-11-17 2003-10-08 Wyeth Aryloxy-piperidinylindole für die behandlung von depressionen
EE200300398A (et) * 2001-02-21 2003-12-15 Janssen Pharmaceutica N.V. Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
US6656950B2 (en) 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
US6800641B2 (en) * 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
US6800648B2 (en) * 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
CZ2004155A3 (cs) 2001-06-29 2004-07-14 H. Lundbeck A/S Název neuveden
UA75407C2 (en) 2001-06-29 2006-04-17 Lundbeck & Co As H Heteroaryl derivatives of pyridine and pyrimidine, pharmaceutical composition and use thereof
WO2003010169A1 (en) 2001-07-25 2003-02-06 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene
EP1492796B1 (de) 2002-04-02 2007-09-05 Janssen Pharmaceutica N.V. Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva
AR040967A1 (es) 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
ES2339444T3 (es) * 2002-08-15 2010-05-20 Janssen Pharmaceutica Nv Derivados de isoxazolina heterociclicos condensados y su uso como antidepresivos.
WO2004018482A2 (en) * 2002-08-21 2004-03-04 Janssen Pharmaceutica N.V. C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants
US7227023B2 (en) * 2003-04-30 2007-06-05 Wyeth Quinoline 3-amino chroman derivatives

Also Published As

Publication number Publication date
AU2005308778B2 (en) 2011-03-24
JP2008521771A (ja) 2008-06-26
US7635696B2 (en) 2009-12-22
CA2585857A1 (en) 2006-06-01
DE602005016836D1 (de) 2009-11-05
US20080113988A1 (en) 2008-05-15
EP1819713A1 (de) 2007-08-22
AU2005308778A1 (en) 2006-06-01
CN101084225B (zh) 2011-03-02
CN101084225A (zh) 2007-12-05
EP1819713B1 (de) 2009-09-23
WO2006056600A1 (en) 2006-06-01
ES2331144T3 (es) 2009-12-22

Similar Documents

Publication Publication Date Title
TW200718692A (en) Dihydrobenzofuran derivatives and uses thereof
TW200719886A (en) Dihydrobenzofuran derivatives and uses thereof
ATE443707T1 (de) Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität
WO2006079637A8 (en) Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
IL177291A0 (en) Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
ECSP077166A (es) Derivados de 3-(heteroaril-oxi)-2-alquil-1-aza-bicicloalquilo como ligandos alfa-7-nachr para el tratamiento de enfermedades del sistema nervioso central (cns)
MX2009009422A (es) Derivados de 3-ciano-piridona 1,4-disustituidos y su uso como moduladores del receptor mglur-2 positivo.
EA200901159A1 (ru) Производные 3-циано-4-(4-фенилпиперидин-1-ил)пиридин-2-она
GEP20104962B (en) Fused heterocyclic compounds
DK1636239T3 (da) Indolderivater med en forbedret antipsykotisk aktivitet
WO2009013212A3 (en) Dual modulators of 5-ht2a and d3 receptors
NO20074977L (no) Fuserte tiazolderivater med affinitet for histamin H3 receptoren
TW200606153A (en) Process for producing pyridine derivatives of Nk-1 receptor antagonist
MX2009004314A (es) Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos.
WO2006061392A3 (en) Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
MX2009004615A (es) Derivados de eter como moduladores duales de los receptores de 5-hidroxitriptamina a (5-ht2a) y dopamina (d3).
TW200613295A (en) Novel unsaturated tetracyclic tetrahydrofuran derivatives
ATE460411T1 (de) Neue tetracyclische tetrahydrofuran-derivate mit cyclischer aminseitenkette
DE602006013040D1 (de) Substituierte pyradinon-derivate als alpha2-adrenorezeptor-antagonisten
NO20084819L (no) Substituerte pyrazinonderivater for anvendelse som en medisin
AU2008258664A8 (en) Prolinamide-tetrazole derivatives as NK3 receptor antagonists
TH69077A (th) อนุพันธ์เฮทเทอโรไซคลิกไอโซแซซอลีนที่หลอมรวม และการใช้สารเป็นยารักษาโรคที่ซึมเศร้า
UA99125C2 (ru) 1,4-замещенные 3-цианопиридонпроизводные и их применение в качестве положительных модуляторов mglur2-рецептора
UA84570C2 (ru) Производные циклопропила как антагонисты рецептора nk3

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties